or
forgot password
  • cancer clinical trials in great falls, MT

  • S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Great Falls Clinic - Main Facility

    Trial Locations
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Lung Cancer
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Lung Cancer
    Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    Sletten Cancer Institute at Benefis Healthcare

    Trial Locations
    Sletten Cancer Institute at Benefis Healthcare
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Sletten Cancer Institute at Benefis Healthcare
    Great Falls, Montana 59405
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Benefis Healthcare- Sletten Cancer Institute
    Endometrial Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Great Falls Clinic - Main Facility

    Trial Locations
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Leukemia
    Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Sletten Cancer Institute at Benefis Healthcare

    Trial Locations
    Sletten Cancer Institute at Benefis Healthcare
    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
    Great Falls Clinic - Main Facility

    Trial Locations
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Leukemia
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Benefis Healthcare- Sletten Cancer Institute

    Trial Locations
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Neuroendocrine Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Benefis Healthcare- Sletten Cancer Institute

    Trial Locations
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Benefis Healthcare- Sletten Cancer Institute

    Trial Locations
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Big Sky Oncology
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Great Falls Clinic, LLP
    Great Falls, Montana 59405
    Venous Thrombosis
    CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
    Benefis Health System - Sletten Cancer Institute
    Great Falls, Montana 59405
    Prostate Cancer, Prostatic Cancer, Prostatic Neoplasms, Prostate Neoplasms, Cancer of the Prostate
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Benefis Healthcare- Sletten Cancer Institute
    Great Falls, Montana 59405
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia